These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 18341375)
1. The EUGOGO consensus statement on the management of Graves' orbitopathy: equally applicable to North American clinicians and patients. Bahn R Thyroid; 2008 Mar; 18(3):281-2. PubMed ID: 18341375 [No Abstract] [Full Text] [Related]
2. Consensus statement of the European group on Graves' orbitopathy (EUGOGO) on management of Graves' orbitopathy. Bartalena L; Baldeschi L; Dickinson AJ; Eckstein A; Kendall-Taylor P; Marcocci C; Mourits MP; Perros P; Boboridis K; Boschi A; Currò N; Daumerie C; Kahaly GJ; Krassas G; Lane CM; Lazarus JH; Marinò M; Nardi M; Neoh C; Orgiazzi J; Pearce S; Pinchera A; Pitz S; Salvi M; Sivelli P; Stahl M; von Arx G; Wiersinga WM Thyroid; 2008 Mar; 18(3):333-46. PubMed ID: 18341379 [No Abstract] [Full Text] [Related]
3. Consensus statement of the European Group on Graves' orbitopathy (EUGOGO) on management of GO. Bartalena L; Baldeschi L; Dickinson A; Eckstein A; Kendall-Taylor P; Marcocci C; Mourits M; Perros P; Boboridis K; Boschi A; Currò N; Daumerie C; Kahaly GJ; Krassas GE; Lane CM; Lazarus JH; Marinò M; Nardi M; Neoh C; Orgiazzi J; Pearce S; Pinchera A; Pitz S; Salvi M; Sivelli P; Stahl M; von Arx G; Wiersinga WM; Eur J Endocrinol; 2008 Mar; 158(3):273-85. PubMed ID: 18299459 [No Abstract] [Full Text] [Related]
4. [Management of Graves' orbitopathy: evidence-based recommendations]. Ponto KA; Pitz S; Mann WJ; Weber MM; Pfeiffer N; Kahaly GJ Dtsch Med Wochenschr; 2009 Dec; 134(49):2521-4. PubMed ID: 19941237 [TBL] [Abstract][Full Text] [Related]
6. Effects of treatment modalities for Graves' hyperthyroidism on Graves' orbitopathy: a 2015 Italian Society of Endocrinology Consensus Statement. Bartalena L; Macchia PE; Marcocci C; Salvi M; Vermiglio F J Endocrinol Invest; 2015 Apr; 38(4):481-7. PubMed ID: 25722226 [No Abstract] [Full Text] [Related]
7. Graves' orbitopathy as a rare disease in Europe: a European Group on Graves' Orbitopathy (EUGOGO) position statement. Perros P; Hegedüs L; Bartalena L; Marcocci C; Kahaly GJ; Baldeschi L; Salvi M; Lazarus JH; Eckstein A; Pitz S; Boboridis K; Anagnostis P; Ayvaz G; Boschi A; Brix TH; Currò N; Konuk O; Marinò M; Mitchell AL; Stankovic B; Törüner FB; von Arx G; Zarković M; Wiersinga WM Orphanet J Rare Dis; 2017 Apr; 12(1):72. PubMed ID: 28427469 [TBL] [Abstract][Full Text] [Related]
8. Survey of common practices among oculofacial surgeons in the Asia-Pacific region: Graves' orbitopathy. Sundar G; Chiam N; Lun K; Koh V Orbit; 2014 Oct; 33(5):319-25. PubMed ID: 25121573 [TBL] [Abstract][Full Text] [Related]
9. Combined thyroid eye clinic: the importance of a multidisciplinary health care in patients with Graves' orbitopathy. Wiersinga WM Pediatr Endocrinol Rev; 2010 Mar; 7 Suppl 2():250-3. PubMed ID: 20467372 [TBL] [Abstract][Full Text] [Related]
18. [The expected and unexpected: key points in the 2021 European Group on Graves' Orbitopathy clinical practice guidelines for the management of Graves' orbitopathy]. Pan Q; Lyu ZH; Guan HX Zhonghua Nei Ke Za Zhi; 2022 Jan; 61(1):8-11. PubMed ID: 34979768 [TBL] [Abstract][Full Text] [Related]